Sahbaee Pooyan, Abadi Ehsan, Segars W Paul, Marin Daniele, Nelson Rendon C, Samei Ehsan
From the Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology, Duke University Medical Center, 2424 Erwin Rd, Suite 302, Durham, NC 27705 (P.S., E.A., W.P.S., D.M., R.C.N., E.S.); and Department of Physics, North Carolina State University, Raleigh, NC (P.S.).
Radiology. 2017 Jun;283(3):749-757. doi: 10.1148/radiol.2017152852. Epub 2017 Mar 13.
Purpose To estimate the radiation dose as a result of contrast medium administration in a typical abdominal computed tomographic (CT) examination across a library of contrast material-enhanced computational patient models. Materials and Methods In part II of this study, first, the technique described in part I of this study was applied to enhance the extended cardiac-torso models with patient-specific iodine-time profiles reflecting the administration of contrast material. Second, the patient models were deployed to assess the patient-specific organ dose as a function of time in a typical abdominal CT examination using Monte Carlo simulation. In this hypothesis-generating study, organ dose refers to the total energy deposited in the unit mass of the tissue inclusive of iodine. Third, a study was performed as a strategy to anticipate the biologically relevant dose (absorbed dose to tissue) in highly perfused organs such as the liver and kidney. The time-varying organ-dose increment values relative to those for unenhanced CT examinations were reported. Results The results from the patient models subjected to the injection protocol indicated up to a total 53%, 30%, 35%, 54%, 27%, 18%, 17%, and 24% increase in radiation dose delivered to the heart, spleen, liver, kidneys, stomach, colon, small intestine, and pancreas, respectively. The biologically relevant dose increase with respect to the dose at an unenhanced CT examination was in the range of 0%-18% increase for the liver and 27% for the kidney across 58 patient models. Conclusion The administration of contrast medium increases the total radiation dose. However, radiation dose, while relevant to be included in estimating the risk associated with contrast-enhanced CT, may still not fully characterize the total biologic effects. Therefore, given the fact that many CT diagnostic decisions would be impossible without the use of iodine, this study suggests the need to consider the effect of iodinated contrast material on the organ doses to patients undergoing CT studies when designing CT protocols. RSNA, 2017 Online supplemental material is available for this article.
目的 通过一系列造影剂增强的计算患者模型,估算典型腹部计算机断层扫描(CT)检查中使用造影剂后的辐射剂量。材料与方法 在本研究的第二部分,首先,应用本研究第一部分中描述的技术,利用反映造影剂给药情况的患者特异性碘时间曲线,增强扩展型心脏-躯干模型。其次,将患者模型用于通过蒙特卡罗模拟评估典型腹部CT检查中作为时间函数的患者特异性器官剂量。在这项产生假设的研究中,器官剂量是指沉积在包括碘在内的组织单位质量中的总能量。第三,开展一项研究,作为预测肝脏和肾脏等高灌注器官中生物相关剂量(组织吸收剂量)的策略。报告了相对于未增强CT检查的随时间变化的器官剂量增量值。结果 接受注射方案的患者模型结果显示,输送到心脏、脾脏、肝脏、肾脏、胃、结肠、小肠和胰腺的辐射剂量分别最多增加53%、30%、35%、54%、27%、18%、17%和24%。在58个患者模型中,相对于未增强CT检查时的剂量,肝脏的生物相关剂量增加幅度在0% - 18%之间,肾脏为27%。结论 造影剂的使用会增加总辐射剂量。然而,辐射剂量虽然在估计与增强CT相关的风险时应予以考虑,但可能仍无法完全表征总的生物学效应。因此,鉴于如果不使用碘,许多CT诊断决策将无法做出,本研究表明在设计CT方案时,需要考虑碘化造影剂对接受CT检查患者器官剂量的影响。RSNA,2017 本文提供在线补充材料。